T-1220 was administered to 27 patients with chronic urinary tract infections.
Twenty cases were available for analysis of clinical evaluation of T-1220. Excellent results were observed in 7 cases, good in 8, and poor in 5. Effective rate was 75%.
Urinary organisms isolated from the patients were 9 Serratia, 5 Pseudomonas, 3 Citrobacter, 2 E. coil and 1 Enterobacter. Clinical effects were observed in all cases of Pseudomonas, E. colt and Enterobacter, 6 of Serratia and 1 of Citrobacter.
As side effect with T-1220, drug eruption was noticed in 1 of 27 cases.
